Person · CIK 1231845

Karin Eastham

Director at Veracyte and Personalis

Earlier: Geron, Nektar Therapeutics, Illumina, Trius Therapeutics, Amylin Pharmaceuticals, Genoptix, Tercica, SGX Pharmaceuticals and Diversa

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$170.8M

Noticed on Form 144$3.8M

Bought on Form 4$0

Companies11

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

Company	Security	Held	Shares or units	As of
Veracyte VCYT	Common Stock	Directly	10,247	Oct 27, 2026 · Filing · EDGAR
Veracyte VCYT	Common Stock	By the Karin Eastham Defined Benefit Plan	13,227	Nov 4, 2013 · Filing · EDGAR
Personalis PSNL	Common Stock	Directly	19,756	May 12, 2026 · Filing · EDGAR
Personalis PSNL	Stock Option (right to buy) exercise $6.04, expires May 12, 2036, into Common Stock	Directly	37,500	May 12, 2026 · Filing · EDGAR
Geron	Common Stock	Directly	109,047	Jan 13, 2023 · Filing · EDGAR
Nektar Therapeutics	Common Stock	Directly	23,233	Sep 16, 2022 · Filing · EDGAR
Nektar Therapeutics	Stock Option exercise $3.47, expires Sep 15, 2030, into Common Stock	Directly	20,400	Sep 16, 2022 · Filing · EDGAR
Illumina	Common Stock	Directly	10,049	May 23, 2019 · Filing · EDGAR
Diversa	Common Stock	Directly	6,419	Apr 29, 2004 · Filing · EDGAR
Diversa	Common Stock	By Minor Children	1,000	Apr 29, 2004 · Filing · EDGAR

Sold and noticed by quarter

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table

Quarter	Sold (Form 4)	Noticed (Form 144)
Q4 2026	$743K	$716K
Q2 2026	$197K	$191K
Q4 2025	$1.3M	$1.3M
Q2 2025	$122K	$123K
Q1 2025	$403K	$396K
Q4 2024	$565K	$541K
Q3 2024	$188K	$188K
Q2 2024	$349K	$349K
Q1 2023	$677K	Not machine-readable
Q3 2022	$77K	Not machine-readable
Q4 2021	$145.3M	Not machine-readable
Q3 2021	$193K	Not machine-readable
Q2 2021	$214K	Not machine-readable
Q1 2021	$379K	Not machine-readable
Q1 2019	$1.5M	Not machine-readable
Q2 2018	$270K	Not machine-readable
Q1 2018	$459K	Not machine-readable
Q3 2017	$2.1M	Not machine-readable
Q2 2016	$727K	Not machine-readable
Q3 2015	$842K	Not machine-readable
Q2 2015	$1M	Not machine-readable
Q1 2015	$3.8M	Not machine-readable
Q4 2014	$1.9M	Not machine-readable
Q2 2014	$945K	Not machine-readable
Q1 2014	$1.1M	Not machine-readable
Q4 2013	$950K	Not machine-readable
Q2 2013	$703K	Not machine-readable
Q2 2012	$419K	Not machine-readable
Q2 2011	$724K	Not machine-readable
Q1 2011	$379K	Not machine-readable
Q2 2010	$421K	Not machine-readable
Q2 2009	$378K	Not machine-readable
Q2 2008	$790K	Not machine-readable
Q2 2004	$458K	Not machine-readable
Q1 2004	$211K	Not machine-readable

Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice date	Noticed	Planned sale	Outcome	Links
Veracyte VCYT · Morgan Stanley Smith Barney · 10b5-1 plan adopted May 28, 2026 · 1 notice
Oct 27, 2026	14,850 · ~$716K	Oct 27, 2026	Sold as noticed Sold 14,850 at $50.00 on Oct 27 · $743K Form 4	Filing · EDGAR
Veracyte VCYT · Morgan Stanley Smith Barney · 10b5-1 plan adopted Sep 5, 2025 · 2 notices
Jun 18, 2026	3,729 · ~$191K	Jun 18, 2026	Sold as noticed Sold 3,729 in 2 sales, Jun 18 to Jun 18 · $197K Form 4	Filing · EDGAR
Dec 5, 2025	20,000 · ~$948K	Dec 5, 2025	Sold as noticed Sold 20,000 in 3 sales, Dec 5 to Dec 5 · $909K Form 4	Filing · EDGAR
Veracyte VCYT · Morgan Stanley Smith Barney · 10b5-1 plan adopted Aug 20, 2024 · 4 notices
Nov 5, 2025	9,674 · ~$349K	Nov 5, 2025	Sold as noticed Sold 9,674 at $40.02 on Nov 5 · $387K Form 4	Filing · EDGAR
Jun 13, 2025	4,590 · ~$123K	Jun 13, 2025	Sold as noticed Sold 4,590 at $26.66 on Jun 13 · $122K Form 4	Filing · EDGAR
Jan 2, 2025	10,000 · ~$396K	Jan 2, 2025	Sold as noticed Sold 10,000 in 2 sales, Jan 2 to Jan 2 · $403K Form 4	Filing · EDGAR
Nov 19, 2024	14,731 · ~$541K	Nov 19, 2024	Sold as noticed Sold 14,731 in 3 sales, Nov 19 to Nov 19 · $565K Form 4	Filing · EDGAR
Veracyte VCYT · Morgan Stanley Smith Barney · 10b5-1 plan adopted Mar 8, 2024 · 3 notices
Jul 16, 2024	7,500 · ~$188K	Jul 16, 2024	Sold as noticed Sold 7,500 at $25.00 on Jul 16 · $188K Form 4	Filing · EDGAR
Jun 11, 2024	3,870 · ~$80K	Jun 11, 2024	Sold as noticed Sold 3,870 at $20.59 on Jun 11 · $80K Form 4	Filing · EDGAR
Jun 7, 2024	2,500 · ~$52K	Jun 7, 2024	Sold as noticed Sold 2,500 at $20.97 on Jun 7 · $52K Form 4	Filing · EDGAR
Veracyte VCYT · Morgan Stanley Smith Barney · 10b5-1 plan adopted Nov 18, 2022 · 1 notice
Apr 1, 2024	10,000 · ~$217K	Apr 1, 2024	Sold as noticed Sold 10,000 at $21.65 on Apr 1 · $217K Form 4	Filing · EDGAR
Sales without a matching Form 144 · 112 sales No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
—	—	—	Notice not machine-readable Veracyte (VCYT): Sold 18,750 at $22.78 on Mar 16, 2023 · $427K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veracyte (VCYT): Sold 10,000 at $25.00 on Feb 28, 2023 · $250K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Nektar Therapeutics: Sold 21,267 at $3.61 on Sep 13, 2022 · $77K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veracyte (VCYT): Sold 5,000 at $45.00 on Dec 17, 2021 · $225K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veracyte (VCYT): Sold 1,241 at $49.48 on Nov 1, 2021 · $61K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veracyte (VCYT): Sold 2,959 at $49,015.00 on Nov 1, 2021 · $145M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veracyte (VCYT): Sold 200 at $47.73 on Nov 1, 2021 · $10K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veracyte (VCYT): Sold 1,554 at $44.57 on Aug 2, 2021 · $69K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veracyte (VCYT): Sold 2,846 at $43.54 on Aug 2, 2021 · $124K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veracyte (VCYT): Sold 250 at $50.03 on May 3, 2021 · $13K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veracyte (VCYT): Sold 650 at $49.00 on May 3, 2021 · $32K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veracyte (VCYT): Sold 3,527 at $48.01 on May 3, 2021 · $169K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veracyte (VCYT): Sold 200 at $61.77 on Feb 25, 2021 · $12K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veracyte (VCYT): Sold 3,606 at $61.09 on Feb 25, 2021 · $220K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Veracyte (VCYT): Sold 2,444 at $60.03 on Feb 25, 2021 · $147K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 100 at $296.78 on Jan 2, 2019 · $30K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 117 at $295.93 on Jan 2, 2019 · $35K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 232 at $294.73 on Jan 2, 2019 · $68K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 350 at $293.59 on Jan 2, 2019 · $103K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 134 at $292.27 on Jan 2, 2019 · $39K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 67 at $291.02 on Jan 2, 2019 · $19K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 466 at $296.57 on Jan 2, 2019 · $138K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 365 at $295.72 on Jan 2, 2019 · $108K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 1,068 at $294.75 on Jan 2, 2019 · $315K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 1,202 at $293.63 on Jan 2, 2019 · $353K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 566 at $292.41 on Jan 2, 2019 · $166K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 333 at $291.03 on Jan 2, 2019 · $97K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 400 at $271.21 on May 21, 2018 · $108K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 400 at $269.29 on May 21, 2018 · $108K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 200 at $268.01 on May 21, 2018 · $54K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 540 at $230.79 on Mar 5, 2018 · $125K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 700 at $230.17 on Mar 5, 2018 · $161K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 200 at $228.60 on Mar 5, 2018 · $46K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 300 at $227.68 on Mar 5, 2018 · $68K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 260 at $226.80 on Mar 5, 2018 · $59K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 10,800 at $195.00 on Aug 2, 2017 · $2.1M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 2,200 at $145.90 on Jun 1, 2016 · $321K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 2,100 at $145.27 on Jun 1, 2016 · $305K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 700 at $143.86 on Jun 1, 2016 · $101K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 4,300 at $195.76 on Sep 8, 2015 · $842K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 100 at $206.97 on Jun 1, 2015 · $21K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 1,568 at $205.69 on Jun 1, 2015 · $323K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 3,332 at $204.98 on Jun 1, 2015 · $683K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 600 at $195.42 on Feb 2, 2015 · $117K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 700 at $194.50 on Feb 2, 2015 · $136K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 2,200 at $193.66 on Feb 2, 2015 · $426K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 2,100 at $192.75 on Feb 2, 2015 · $405K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 3,100 at $191.96 on Feb 2, 2015 · $595K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 1,300 at $191.08 on Feb 2, 2015 · $248K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 400 at $189.11 on Jan 2, 2015 · $76K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 600 at $187.82 on Jan 2, 2015 · $113K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 1,300 at $186.43 on Jan 2, 2015 · $242K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 5,908 at $185.32 on Jan 2, 2015 · $1.1M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 1,792 at $184.54 on Jan 2, 2015 · $331K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 100 at $194.74 on Dec 4, 2014 · $19K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 1,900 at $194.17 on Dec 4, 2014 · $369K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 609 at $192.88 on Dec 4, 2014 · $117K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 3,100 at $191.62 on Dec 4, 2014 · $594K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 4,291 at $190.83 on Dec 4, 2014 · $819K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 66 at $159.57 on Jun 2, 2014 · $11K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 1,700 at $158.69 on Jun 2, 2014 · $270K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 2,789 at $157.81 on Jun 2, 2014 · $440K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 731 at $156.44 on Jun 2, 2014 · $114K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 514 at $155.22 on Jun 2, 2014 · $80K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 200 at $153.79 on Jun 2, 2014 · $31K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 1,300 at $110.12 on Jan 2, 2014 · $143K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 8,700 at $109.40 on Jan 2, 2014 · $952K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 2,345 at $95.58 on Nov 1, 2013 · $224K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 6,855 at $94.92 on Nov 1, 2013 · $651K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 800 at $93.89 on Nov 1, 2013 · $75K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 5,030 at $70.63 on Jun 3, 2013 · $355K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 4,970 at $70.05 on Jun 3, 2013 · $348K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 6,000 at $42.08 on Jun 1, 2012 · $253K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 4,000 at $41.72 on Jun 1, 2012 · $167K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 1,000 at $72.73 on Jun 1, 2011 · $73K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 9,000 at $72.39 on Jun 1, 2011 · $651K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 476 at $63.45 on Mar 17, 2011 · $30K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 3,524 at $62.80 on Mar 17, 2011 · $221K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 2,000 at $63.83 on Mar 17, 2011 · $128K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 10,000 at $42.12 on Jun 1, 2010 · $421K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 10,000 at $37.82 on Jun 1, 2009 · $378K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 10,000 at $79.03 on Jun 2, 2008 · $790K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 590 at $10.50 on Apr 29, 2004 · $6K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 9,410 at $10.50 on Apr 29, 2004 · $99K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 300 at $10.34 on Apr 26, 2004 · $3K	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 4,796 at $10.33 on Apr 26, 2004 · $50K	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 1,500 at $10.30 on Apr 26, 2004 · $15K	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 600 at $10.20 on Apr 26, 2004 · $6K	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 8,836 at $10.10 on Apr 26, 2004 · $89K	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 5,000 at $10.05 on Apr 26, 2004 · $50K	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 2,800 at $10.01 on Apr 26, 2004 · $28K	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 11,168 at $10.00 on Apr 26, 2004 · $112K	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 1,112 at $10.50 on Jan 15, 2004 · $12K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 100 at $10.82 on Jan 14, 2004 · $1K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 500 at $10.76 on Jan 14, 2004 · $5K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 500 at $10.74 on Jan 14, 2004 · $5K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 500 at $10.73 on Jan 14, 2004 · $5K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 400 at $10.71 on Jan 14, 2004 · $4K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 1,600 at $10.70 on Jan 14, 2004 · $17K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 300 at $10.67 on Jan 14, 2004 · $3K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 200 at $10.66 on Jan 14, 2004 · $2K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 100 at $10.65 on Jan 14, 2004 · $1K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 300 at $10.61 on Jan 14, 2004 · $3K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 300 at $10.60 on Jan 14, 2004 · $3K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 200 at $10.55 on Jan 14, 2004 · $2K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 1,100 at $10.50 on Jan 14, 2004 · $12K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 300 at $10.51 on Jan 13, 2004 · $3K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 1,000 at $10.50 on Jan 13, 2004 · $11K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 100 at $10.56 on Jan 13, 2004 · $1K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 388 at $10.61 on Jan 13, 2004 · $4K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 10,000 at $10.50 on Jan 12, 2004 · $105K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Diversa: Sold 1,000 at $10.52 on Jan 12, 2004 · $11K (10b5-1 plan)	Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Veracyte VCYT Director · filings 2013 to 2026 · sold $150.7M · $3.8M noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Oct 27, 2026	Option or RSU exercised or converted	+10,000	$27.01	$270K	25,097 direct	Filing · EDGAR
Oct 27, 2026	Sale under a 10b5-1 plan	−14,850	$50.00	$743K	10,247 direct	Filing · EDGAR
Oct 27, 2026	Option or RSU exercised or converted Stock Option (right to buy)	−10,000			0 direct	Filing · EDGAR
Jun 18, 2026	Sale under a 10b5-1 plan	−3,200	$52.78	$169K	15,626 direct	Filing · EDGAR
Jun 18, 2026	Sale under a 10b5-1 plan	−529	$53.55	$28K	15,097 direct	Filing · EDGAR
Jun 11, 2026	Grant or award from the company	+5,272			18,826 direct	Filing · EDGAR
Dec 5, 2025	Option or RSU exercised or converted	+10,000	$7.94	$79K	23,554 direct	Filing · EDGAR
Dec 5, 2025	Option or RSU exercised or converted	+10,000	$7.60	$76K	33,554 direct	Filing · EDGAR
Dec 5, 2025	Sale under a 10b5-1 plan	−6,392	$44.52	$285K	27,162 direct	Filing · EDGAR
Dec 5, 2025	Sale under a 10b5-1 plan	−12,808	$45.84	$587K	14,354 direct	Filing · EDGAR
Dec 5, 2025	Sale under a 10b5-1 plan	−800	$46.59	$37K	13,554 direct	Filing · EDGAR
Dec 5, 2025	Option or RSU exercised or converted Stock Option (right to buy)	−10,000			0 direct	Filing · EDGAR
Dec 5, 2025	Option or RSU exercised or converted Stock Option (right to buy)	−10,000			0 direct	Filing · EDGAR
Nov 5, 2025	Sale under a 10b5-1 plan	−9,674	$40.02	$387K	13,554 direct	Filing · EDGAR
Jun 18, 2025	Grant or award from the company	+9,321			23,228 direct	Filing · EDGAR
Jun 13, 2025	Sale under a 10b5-1 plan	−4,590	$26.66	$122K	13,907 direct	Filing · EDGAR
Jan 2, 2025	Option or RSU exercised or converted	+10,000	$5.28	$53K	28,497 direct	Filing · EDGAR
Jan 2, 2025	Sale under a 10b5-1 plan	−5,309	$40.12	$213K	23,188 direct	Filing · EDGAR
Jan 2, 2025	Sale under a 10b5-1 plan	−4,691	$40.50	$190K	18,497 direct	Filing · EDGAR
Jan 2, 2025	Option or RSU exercised or converted Stock Option (right to buy)	−10,000			0 direct	Filing · EDGAR
Nov 19, 2024	Sale under a 10b5-1 plan	−1,600	$36.77	$59K	31,628 direct	Filing · EDGAR
Nov 19, 2024	Sale under a 10b5-1 plan	−3,006	$37.77	$114K	28,622 direct	Filing · EDGAR
Nov 19, 2024	Sale under a 10b5-1 plan	−10,125	$38.76	$392K	18,497 direct	Filing · EDGAR
Jul 16, 2024	Sale under a 10b5-1 plan	−7,500	$25.00	$188K	33,228 direct	Filing · EDGAR
Jun 13, 2024	Grant or award from the company	+11,473			40,728 direct	Filing · EDGAR
Jun 11, 2024	Sale under a 10b5-1 plan	−3,870	$20.59	$80K	29,255 direct	Filing · EDGAR
Jun 7, 2024	Option or RSU exercised or converted	+2,500	$10.41	$26K	35,625 direct	Filing · EDGAR
Jun 7, 2024	Sale under a 10b5-1 plan	−2,500	$20.97	$52K	33,125 direct	Filing · EDGAR
Jun 7, 2024	Option or RSU exercised or converted Stock Option (right to buy)	−2,500			7,500 direct	Filing · EDGAR
Apr 1, 2024	Option or RSU exercised or converted	+10,000	$13.19	$132K	43,125 direct	Filing · EDGAR
Apr 1, 2024	Sale under a 10b5-1 plan	−10,000	$21.65	$217K	33,125 direct	Filing · EDGAR
Apr 1, 2024	Option or RSU exercised or converted Stock Option (right to buy)	−10,000	$13.19	$132K	0 direct	Filing · EDGAR
Jun 9, 2023	Grant or award from the company	+9,674			33,125 direct	Filing · EDGAR
Mar 16, 2023	Option or RSU exercised or converted	+18,750	$12.12	$227K	42,201 direct	Filing · EDGAR
Mar 16, 2023	Sale under a 10b5-1 plan	−18,750	$22.78	$427K	23,451 direct	Filing · EDGAR
Mar 16, 2023	Option or RSU exercised or converted Stock Option (right to buy)	−18,750			0 direct	Filing · EDGAR
Feb 28, 2023	Option or RSU exercised or converted	+10,000	$12.12	$121K	33,451 direct	Filing · EDGAR
Feb 28, 2023	Sale under a 10b5-1 plan	−10,000	$25.00	$250K	23,451 direct	Filing · EDGAR
Feb 28, 2023	Option or RSU exercised or converted Stock Option (right to buy)	−10,000			18,750 direct	Filing · EDGAR
Jun 16, 2022	Grant or award from the company	+14,731			23,451 direct	Filing · EDGAR
Dec 17, 2021	Option or RSU exercised or converted	+5,000	$12.12	$61K	13,720 direct	Filing · EDGAR
Dec 17, 2021	Sale under a 10b5-1 plan	−5,000	$45.00	$225K	8,720 direct	Filing · EDGAR
Dec 17, 2021	Option or RSU exercised or converted Stock Option (right to buy)	−5,000			28,750 direct	Filing · EDGAR
Nov 1, 2021	Sale under a 10b5-1 plan	−200	$47.73	$10K	4,200 By IRA	Filing · EDGAR
Nov 1, 2021	Sale under a 10b5-1 plan	−2,959	$49,015.00	$145M	1,241 By IRA	Filing · EDGAR
Nov 1, 2021	Sale under a 10b5-1 plan	−1,241	$49.48	$61K	0 By IRA	Filing · EDGAR
Aug 2, 2021	Sale under a 10b5-1 plan	−2,846	$43.54	$124K	5,954 By IRA	Filing · EDGAR
Aug 2, 2021	Sale under a 10b5-1 plan	−1,554	$44.57	$69K	4,400 By IRA	Filing · EDGAR
Jun 8, 2021	Grant or award from the company	+8,720			8,720 direct	Filing · EDGAR
May 3, 2021	Sale under a 10b5-1 plan	−3,527	$48.01	$169K	9,700 By IRA	Filing · EDGAR
May 3, 2021	Sale under a 10b5-1 plan	−650	$49.00	$32K	9,050 By IRA	Filing · EDGAR
May 3, 2021	Sale under a 10b5-1 plan	−250	$50.03	$13K	8,800 By IRA	Filing · EDGAR
Feb 25, 2021	Option or RSU exercised or converted	+6,250	$4.00	$25K	6,250 direct	Filing · EDGAR
Feb 25, 2021	Sale under a 10b5-1 plan	−2,444	$60.03	$147K	3,806 direct	Filing · EDGAR
Feb 25, 2021	Sale under a 10b5-1 plan	−3,606	$61.09	$220K	200 direct	Filing · EDGAR
Feb 25, 2021	Sale under a 10b5-1 plan	−200	$61.77	$12K	0 direct	Filing · EDGAR
Feb 25, 2021	Option or RSU exercised or converted Stock Option (right to buy)	−6,250			0 direct	Filing · EDGAR
Jun 8, 2020	Grant or award from the company Stock Option (right to buy)	+10,000			10,000 direct	Filing · EDGAR
Jun 12, 2019	Grant or award from the company Stock Option (right to buy)	+10,000			10,000 direct	Filing · EDGAR
Jun 7, 2018	Grant or award from the company Stock Option (right to buy)	+10,000			10,000 direct	Filing · EDGAR

6 earlier transactions are in the filing list below.

Personalis PSNL Director · filings 2019 to 2026

Date	Transaction	Shares	Held after	Source
May 12, 2026	Grant or award from the company	+6,250	19,756 direct	Filing · EDGAR
May 12, 2026	Grant or award from the company Stock Option (right to buy)	+37,500	37,500 direct	Filing · EDGAR
May 16, 2025	Grant or award from the company Stock Option (right to buy)	+50,000	50,000 direct	Filing · EDGAR
May 17, 2024	Grant or award from the company Stock Option (right to buy)	+50,000	50,000 direct	Filing · EDGAR
May 17, 2023	Grant or award from the company Stock Option (right to buy)	+40,000	40,000 direct	Filing · EDGAR
May 17, 2022	Grant or award from the company	+10,770	13,506 direct	Filing · EDGAR
May 17, 2022	Grant or award from the company Stock Option (right to buy)	+15,035	15,035 direct	Filing · EDGAR
May 14, 2021	Grant or award from the company	+2,736	2,736 direct	Filing · EDGAR
May 14, 2021	Grant or award from the company Stock Option (right to buy)	+4,229	4,229 direct	Filing · EDGAR
May 15, 2020	Grant or award from the company Stock Option (right to buy)	+14,000	14,000 direct	Filing · EDGAR
Sep 9, 2019	Grant or award from the company Stock Option (right to buy)	+24,000	24,000 direct	Filing · EDGAR

Geron Director · filings 2009 to 2023

Date	Transaction	Shares	Price	Value	Held after	Source
Jan 13, 2023	Option or RSU exercised or converted	+35,000	$1.10	$39K	109,047 direct	Filing · EDGAR
Jan 13, 2023	Option or RSU exercised or converted Stock Options (right to buy)	−35,000			0 direct	Filing · EDGAR
May 10, 2022	Grant or award from the company Stock Option (right to buy)	+125,000			125,000 direct	Filing · EDGAR
Apr 20, 2022	Option or RSU exercised or converted	+35,000	$1.41	$49K	74,047 direct	Filing · EDGAR
Apr 20, 2022	Option or RSU exercised or converted Stock Option (right to buy)	−35,000			0 direct	Filing · EDGAR
May 11, 2021	Grant or award from the company Stock Option (right to buy)	+83,000			83,000 direct	Filing · EDGAR
Jun 5, 2020	Grant or award from the company Stock Option (right to buy)	+83,000			83,000 direct	Filing · EDGAR
Jun 6, 2019	Grant or award from the company Stock Option (right to buy)	+70,000			70,000 direct	Filing · EDGAR
May 15, 2018	Grant or award from the company Stock Option (right to buy)	+70,000			70,000 direct	Filing · EDGAR
May 9, 2017	Grant or award from the company Stock Option (right to buy)	+50,000			50,000 direct	Filing · EDGAR
May 17, 2016	Grant or award from the company Stock Option (right to buy)	+50,000			50,000 direct	Filing · EDGAR
May 18, 2015	Grant or award from the company Stock Option (right to buy)	+35,000			35,000 direct	Filing · EDGAR
Dec 31, 2014	Grant or award from the company	+5,577	$3.25	$18K	39,047 direct	Filing · EDGAR
Jun 30, 2014	Grant or award from the company	+5,646	$3.21	$18K	35,970 direct	Filing · EDGAR
Jun 30, 2014	Returned to the company	−2,500			33,470 direct	Filing · EDGAR
May 20, 2014	Grant or award from the company Stock Option (right to buy)	+35,000			35,000 direct	Filing · EDGAR
Dec 31, 2013	Grant or award from the company	+3,824	$4.74	$18K	30,324 direct	Filing · EDGAR
Jul 9, 2013	Returned to the company	−45,000			26,500 direct	Filing · EDGAR
May 22, 2013	Grant or award from the company Stock Option (right to buy)	+35,000			35,000 direct	Filing · EDGAR
Dec 31, 2012	Returned to the company	−2,500			71,500 direct	Filing · EDGAR
May 17, 2012	Grant or award from the company Stock Option (right to buy)	+35,000			35,000 direct	Filing · EDGAR
May 20, 2011	Grant or award from the company	+2,500			71,500 direct	Filing · EDGAR
May 20, 2011	Grant or award from the company	+2,500			74,000 direct	Filing · EDGAR
May 11, 2011	Grant or award from the company	+9,000			69,000 direct	Filing · EDGAR
May 11, 2011	Grant or award from the company Stock Option (right to buy)	+18,000			18,000 direct	Filing · EDGAR
May 11, 2011	Grant or award from the company Stock Option (right to buy)	+15,000			15,000 direct	Filing · EDGAR
Jul 9, 2010	Grant or award from the company	+9,000			24,000 direct	Filing · EDGAR
Jul 9, 2010	Grant or award from the company	+9,000			33,000 direct	Filing · EDGAR
Jul 9, 2010	Grant or award from the company	+9,000			42,000 direct	Filing · EDGAR
Jul 9, 2010	Grant or award from the company	+18,000			60,000 direct	Filing · EDGAR
May 19, 2010	Grant or award from the company	+7,500			15,000 direct	Filing · EDGAR
May 19, 2010	Grant or award from the company Stock Option (right to buy)	+15,000			15,000 direct	Filing · EDGAR
May 29, 2009	Grant or award from the company	+7,500			7,500 direct	Filing · EDGAR
May 29, 2009	Grant or award from the company Stock Option (right to buy)	+15,000	$6.52	$98K	62,500 direct	Filing · EDGAR

Nektar Therapeutics Director · filings 2018 to 2022 · sold $77K

Date	Transaction	Shares	Price	Value	Held after	Source
Sep 16, 2022	Grant or award from the company	+10,200			23,233 direct	Filing · EDGAR
Sep 16, 2022	Grant or award from the company Stock Option	+20,400			20,400 direct	Filing · EDGAR
Sep 13, 2022	Sale under a 10b5-1 plan	−21,267	$3.61	$77K	13,033 direct	Filing · EDGAR
Sep 22, 2021	Grant or award from the company	+10,200			34,300 direct	Filing · EDGAR
Sep 22, 2021	Grant or award from the company Stock Option	+20,400			20,400 direct	Filing · EDGAR
Sep 22, 2020	Grant or award from the company	+9,100			24,100 direct	Filing · EDGAR
Sep 22, 2020	Grant or award from the company Stock Option	+18,200			18,200 direct	Filing · EDGAR
Sep 25, 2019	Grant or award from the company	+6,500			15,000 direct	Filing · EDGAR
Sep 25, 2019	Grant or award from the company Stock Option	+13,000			13,000 direct	Filing · EDGAR
Sep 27, 2018	Grant or award from the company	+8,500			8,500 direct	Filing · EDGAR
Sep 27, 2018	Grant or award from the company Stock Option	+17,000			17,000 direct	Filing · EDGAR

Illumina Director · filings 2004 to 2019 · sold $19.4M

Date	Transaction	Shares	Price	Value	Held after	Source
May 23, 2019	Shares withheld for tax or exercise price	−589	$308.97	$182K	10,049 direct	Filing · EDGAR
Jan 2, 2019	Option or RSU exercised or converted	+4,000	$71.09	$284K	15,838 direct	Filing · EDGAR
Jan 2, 2019	Sale under a 10b5-1 plan	−333	$291.03	$97K	15,505 direct	Filing · EDGAR
Jan 2, 2019	Sale under a 10b5-1 plan	−566	$292.41	$166K	14,939 direct	Filing · EDGAR
Jan 2, 2019	Sale under a 10b5-1 plan	−1,202	$293.63	$353K	13,737 direct	Filing · EDGAR
Jan 2, 2019	Sale under a 10b5-1 plan	−1,068	$294.75	$315K	12,669 direct	Filing · EDGAR
Jan 2, 2019	Sale under a 10b5-1 plan	−365	$295.72	$108K	12,304 direct	Filing · EDGAR
Jan 2, 2019	Sale under a 10b5-1 plan	−466	$296.57	$138K	11,838 direct	Filing · EDGAR
Jan 2, 2019	Sale under a 10b5-1 plan	−67	$291.02	$19K	11,771 direct	Filing · EDGAR
Jan 2, 2019	Sale under a 10b5-1 plan	−134	$292.27	$39K	11,637 direct	Filing · EDGAR
Jan 2, 2019	Sale under a 10b5-1 plan	−350	$293.59	$103K	11,287 direct	Filing · EDGAR
Jan 2, 2019	Sale under a 10b5-1 plan	−232	$294.73	$68K	11,055 direct	Filing · EDGAR
Jan 2, 2019	Sale under a 10b5-1 plan	−117	$295.93	$35K	10,938 direct	Filing · EDGAR
Jan 2, 2019	Sale under a 10b5-1 plan	−100	$296.78	$30K	10,838 direct	Filing · EDGAR
Jan 2, 2019	Option or RSU exercised or converted Non-qualified Stock Option (Right to Buy)	−4,000			1,600 direct	Filing · EDGAR
Dec 3, 2018	Gift	−44			11,838 direct	Filing · EDGAR
Nov 28, 2018	Gift	−458			11,882 direct	Filing · EDGAR
Nov 27, 2018	Gift	−315			12,340 direct	Filing · EDGAR
Nov 6, 2018	Gift	−184			12,655 direct	Filing · EDGAR
May 23, 2018	Grant or award from the company	+1,473			12,839 direct	Filing · EDGAR
May 22, 2018	Shares withheld for tax or exercise price	−922	$270.80	$250K	11,366 direct	Filing · EDGAR
May 21, 2018	Sale under a 10b5-1 plan	−200	$268.01	$54K	13,088 direct	Filing · EDGAR
May 21, 2018	Sale under a 10b5-1 plan	−400	$269.29	$108K	12,688 direct	Filing · EDGAR
May 21, 2018	Sale under a 10b5-1 plan	−400	$271.21	$108K	12,288 direct	Filing · EDGAR
Mar 5, 2018	Option or RSU exercised or converted	+2,000	$71.09	$142K	15,288 direct	Filing · EDGAR
Mar 5, 2018	Sale under a 10b5-1 plan	−260	$226.80	$59K	15,028 direct	Filing · EDGAR
Mar 5, 2018	Sale under a 10b5-1 plan	−300	$227.68	$68K	14,728 direct	Filing · EDGAR
Mar 5, 2018	Sale under a 10b5-1 plan	−200	$228.60	$46K	14,528 direct	Filing · EDGAR
Mar 5, 2018	Sale under a 10b5-1 plan	−700	$230.17	$161K	13,828 direct	Filing · EDGAR
Mar 5, 2018	Sale under a 10b5-1 plan	−540	$230.79	$125K	13,288 direct	Filing · EDGAR
Mar 5, 2018	Option or RSU exercised or converted Non-qualified Stock Option (Right to Buy)	−2,000			5,600 direct	Filing · EDGAR
Aug 2, 2017	Option or RSU exercised or converted	+10,800	$75.66	$817K	24,388 direct	Filing · EDGAR
Aug 2, 2017	Sale under a 10b5-1 plan	−10,800	$195.00	$2.1M	13,588 direct	Filing · EDGAR
Aug 2, 2017	Option or RSU exercised or converted Non-qualified Stock Option (Right to Buy)	−10,800			0 direct	Filing · EDGAR
May 30, 2017	Grant or award from the company	+2,305			13,588 direct	Filing · EDGAR
May 18, 2017	Shares withheld for tax or exercise price	−1,141	$175.89	$201K	11,283 direct	Filing · EDGAR
Jun 7, 2016	Gift	−300			13,288 direct	Filing · EDGAR
Jun 1, 2016	Option or RSU exercised or converted	+5,000	$36.29	$181K	17,424 direct	Filing · EDGAR
Jun 1, 2016	Sale under a 10b5-1 plan	−700	$143.86	$101K	16,724 direct	Filing · EDGAR
Jun 1, 2016	Sale under a 10b5-1 plan	−2,100	$145.27	$305K	14,624 direct	Filing · EDGAR
Jun 1, 2016	Sale under a 10b5-1 plan	−2,200	$145.90	$321K	12,424 direct	Filing · EDGAR
Jun 1, 2016	Option or RSU exercised or converted Non-qualified Stock Option (Right to Buy)	−5,000			0 direct	Filing · EDGAR
May 18, 2016	Grant or award from the company	+2,853			12,424 direct	Filing · EDGAR
May 17, 2016	Shares withheld for tax or exercise price	−764	$138.77	$106K	9,571 direct	Filing · EDGAR
Dec 9, 2015	Gift	−84			10,335 direct	Filing · EDGAR
Sep 8, 2015	Option or RSU exercised or converted	+4,300	$44.51	$191K	14,719 direct	Filing · EDGAR
Sep 8, 2015	Sale under a 10b5-1 plan	−4,300	$195.76	$842K	10,419 direct	Filing · EDGAR
Sep 8, 2015	Option or RSU exercised or converted Non-qualified Stock Option (Right to Buy)	−4,300			0 direct	Filing · EDGAR
Jun 1, 2015	Option or RSU exercised or converted	+5,000	$39.14	$196K	15,419 direct	Filing · EDGAR
Jun 1, 2015	Sale under a 10b5-1 plan	−3,332	$204.98	$683K	12,087 direct	Filing · EDGAR
Jun 1, 2015	Sale under a 10b5-1 plan	−1,568	$205.69	$323K	10.52 direct	Filing · EDGAR
Jun 1, 2015	Sale under a 10b5-1 plan	−100	$206.97	$21K	10,419 direct	Filing · EDGAR
Jun 1, 2015	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	+5,000			0 direct	Filing · EDGAR
May 27, 2015	Grant or award from the company	+1,910			10,419 direct	Filing · EDGAR
May 26, 2015	Shares withheld for tax or exercise price	−1,017	$205.09	$209K	8,509 direct	Filing · EDGAR
Feb 2, 2015	Option or RSU exercised or converted	+6,500	$44.51	$289K	16,226 direct	Filing · EDGAR
Feb 2, 2015	Sale under a 10b5-1 plan	−1,300	$191.08	$248K	14,926 direct	Filing · EDGAR
Feb 2, 2015	Sale under a 10b5-1 plan	−3,100	$191.96	$595K	11,826 direct	Filing · EDGAR
Feb 2, 2015	Sale under a 10b5-1 plan	−2,100	$192.75	$405K	9,726 direct	Filing · EDGAR
Feb 2, 2015	Option or RSU exercised or converted	+3,500	$42.82	$150K	13,226 direct	Filing · EDGAR

93 earlier transactions are in the filing list below.

Trius Therapeutics Director · filings 2010 to 2013

Date	Transaction	Shares	Price	Value	Held after	Source
Sep 11, 2013	Returned to the company	−6,000	$13.50	$81K	0 direct	Filing · EDGAR
Sep 11, 2013	Returned to the company	−12,114	$13.50	$164K	0 Karin Eastham Defined Benefit Plan	Filing · EDGAR
Sep 11, 2013	Returned to the company Stock Option (right to buy)	−17,441	$5.93	$103K	0 direct	Filing · EDGAR
Sep 11, 2013	Returned to the company Stock Option (right to buy)	−6,000	$10.00	$60K	0 direct	Filing · EDGAR
Sep 11, 2013	Returned to the company Stock Option (right to buy)	−12,000	$5.24	$63K	0 direct	Filing · EDGAR
Sep 11, 2013	Returned to the company Stock Option (right to buy)	−12,000	$8.45	$101K	0 direct	Filing · EDGAR
Sep 11, 2013	Returned to the company Stock Option (right to buy)	−15,000	$5.73	$86K	0 direct	Filing · EDGAR
May 21, 2013	Grant or award from the company Stock Option (right to buy)	+15,000			15,000 direct	Filing · EDGAR
May 22, 2012	Grant or award from the company Stock Option (right to buy)	+12,000			12,000 direct	Filing · EDGAR
Mar 27, 2012	Option or RSU exercised or converted	+6,000	$3.50	$21K	18,114 direct	Filing · EDGAR
Mar 27, 2012	Option or RSU exercised or converted Stock Option (right to buy)	−6,000			6,000 direct	Filing · EDGAR
Jun 2, 2011	Grant or award from the company Stock Option (right to buy)	+12,000			12,000 direct	Filing · EDGAR
Nov 3, 2010	Grant or award from the company Stock Option (right to buy)	+12,000			12,000 direct	Filing · EDGAR
Aug 6, 2010	Derivative converted	+12,114	$4.38	$53K	12,114 direct	Filing · EDGAR

Amylin Pharmaceuticals Director · filings 2005 to 2012

Date	Transaction	Shares	Price	Value	Held after	Source
Aug 8, 2012	Other acquisition or disposition (see the filing)	−6,000	$31.00	$186K	0 direct	Filing · EDGAR
Aug 8, 2012	Other acquisition or disposition (see the filing) Non-Qualified Stock Option (right to buy)	−20,000	$31.00	$620K	0 direct	Filing · EDGAR
Aug 8, 2012	Other acquisition or disposition (see the filing) Non-Qualified Stock Option (right to buy)	−20,000	$31.00	$620K	0 direct	Filing · EDGAR
Aug 8, 2012	Other acquisition or disposition (see the filing) Non-Qualified Stock Option (right to buy)	−20,000	$31.00	$620K	0 direct	Filing · EDGAR
Aug 8, 2012	Other acquisition or disposition (see the filing) Non-Qualified Stock Option (right to buy)	−20,000	$31.00	$620K	0 direct	Filing · EDGAR
Aug 8, 2012	Other acquisition or disposition (see the filing) Non-Qualified Stock Option (right to buy)	−20,000	$31.00	$620K	0 direct	Filing · EDGAR
Aug 8, 2012	Long derivative expired or cancelled Non-Qualified Stock Option (right to buy)	−12,000			0 direct	Filing · EDGAR
Aug 8, 2012	Long derivative expired or cancelled Non-Qualified Stock Option (right to buy)	−12,000			0 direct	Filing · EDGAR
Aug 8, 2012	Long derivative expired or cancelled Non-Qualified Stock Option (right to buy)	−12,000			0 direct	Filing · EDGAR
Aug 8, 2012	Other acquisition or disposition (see the filing) Phantom Stock-Deferred Compensation	−11,971	$31.00	$371K	3,273 direct	Filing · EDGAR
Aug 8, 2012	Other acquisition or disposition (see the filing) Phantom Stock-Deferred Compensation	−3,273	$31.00	$101K	0 direct	Filing · EDGAR
May 15, 2012	Grant or award from the company	+3,000			6,000 direct	Filing · EDGAR
May 15, 2012	Grant or award from the company Non-Qualified Stock Option (right to buy)	+20,000			20,000 direct	Filing · EDGAR
May 24, 2011	Grant or award from the company	+3,000			3,000 direct	Filing · EDGAR
May 24, 2011	Grant or award from the company Non-Qualified Stock Option (right to buy)	+20,000			20,000 direct	Filing · EDGAR
Apr 29, 2010	Grant or award from the company Non-Qualified Stock Option (right to buy)	+20,000			20,000 direct	Filing · EDGAR
Oct 2, 2009	Grant or award from the company Phantom Stock-Deferred Compensation	+1,627	$13.06	$21K	15,244 direct	Filing · EDGAR
Jul 2, 2009	Grant or award from the company Phantom Stock-Deferred Compensation	+1,646	$12.91	$21K	13,617 direct	Filing · EDGAR
May 27, 2009	Grant or award from the company Non-Qualified Stock Option (right to buy)	+20,000			20,000 direct	Filing · EDGAR
Apr 3, 2009	Grant or award from the company Phantom Stock-Deferred Compensation	+3,812	$9.51	$36K	11,971 direct	Filing · EDGAR
Jan 13, 2009	Grant or award from the company Phantom Stock-Deferred Compensation	+1,824	$11.64	$21K	8,159 direct	Filing · EDGAR
Oct 3, 2008	Grant or award from the company Phantom Stock-Deferred Compensation	+1,111	$19.12	$21K	6,335 direct	Filing · EDGAR
Jul 2, 2008	Grant or award from the company Phantom Stock-Deferred Compensation	+810	$26.22	$21K	5,224 direct	Filing · EDGAR
May 30, 2008	Grant or award from the company Non-Qualified Stock Option (right to buy)	+12,000			12,000 direct	Filing · EDGAR
Apr 2, 2008	Grant or award from the company Phantom Stock-Deferred Compensation	+663	$32.03	$21K	4,414 direct	Filing · EDGAR
Jan 10, 2008	Grant or award from the company Phantom Stock-Deferred Compensation	+602	$35.25	$21K	3,751 direct	Filing · EDGAR
Oct 4, 2007	Grant or award from the company Phantom Stock-Deferred Compensation	+425	$49.92	$21K	3,149 direct	Filing · EDGAR
Jul 6, 2007	Grant or award from the company Phantom Stock-Deferred Compensation	+505	$42.05	$21K	2,724 direct	Filing · EDGAR
May 23, 2007	Grant or award from the company Non-Qualified Stock Option (right to buy)	+12,000			12,000 direct	Filing · EDGAR
Apr 3, 2007	Grant or award from the company Phantom Stock-Deferred Compensation	+561	$37.86	$21K	2,219 direct	Filing · EDGAR
Feb 23, 2007	Grant or award from the company Phantom Stock-Deferred Compensation	+154	$40.48	$6K	1,658 direct	Filing · EDGAR
Jan 12, 2007	Grant or award from the company Phantom Stock-Deferred Compensation	+311	$40.11	$12K	1,504 direct	Filing · EDGAR
Oct 5, 2006	Grant or award from the company Phantom Stock-Deferred Compensation	+285	$43.74	$12K	1,193 direct	Filing · EDGAR
Jul 13, 2006	Grant or award from the company Phantom Stock-Deferred Compensation	+252	$49.44	$12K	908 direct	Filing · EDGAR
May 17, 2006	Grant or award from the company Non-Qualified Stock Option (right to buy)	+12,000			12,000 direct	Filing · EDGAR
Apr 5, 2006	Grant or award from the company Phantom Stock-Deferred Compensation	+189	$46.16	$9K	656 direct	Filing · EDGAR
Jan 5, 2006	Grant or award from the company Phantom Stock-Deferred Compensation	+217	$40.25	$9K	467 direct	Filing · EDGAR
Oct 7, 2005	Grant or award from the company Phantom Stock-Deferred Compensation	+250	$34.87	$9K	250 direct	Filing · EDGAR

Genoptix Director · filings 2008 to 2011

Date	Transaction	Shares	Price	Value	Held after	Source
Mar 4, 2011	Tendered in a change of control	−2,500	$25.00	$63K	0 direct	Filing · EDGAR
Feb 25, 2011	Tendered in a change of control	−6,000	$25.00	$150K	2,500 direct	Filing · EDGAR
Dec 1, 2010	Returned to the company	−250	$16.93	$4K	8,500 direct	Filing · EDGAR
Sep 1, 2010	Returned to the company	−250	$17.70	$4K	8,750 direct	Filing · EDGAR
Jun 2, 2010	Returned to the company	−250	$25.78	$6K	9,000 direct	Filing · EDGAR
Jun 1, 2010	Grant or award from the company	+2,500			9,250 direct	Filing · EDGAR
Jun 1, 2010	Grant or award from the company Stock Option (Right to Buy)	+3,750			3,750 direct	Filing · EDGAR
Mar 2, 2010	Returned to the company	−250	$32.40	$8K	6,750 direct	Filing · EDGAR
Dec 2, 2009	Returned to the company	−250	$37.29	$9K	7,000 direct	Filing · EDGAR
Sep 2, 2009	Returned to the company	−250	$30.39	$8K	7,250 direct	Filing · EDGAR
Jun 2, 2009	Grant or award from the company	+2,500			7,500 direct	Filing · EDGAR
Jun 2, 2009	Grant or award from the company Stock Option (Right to Buy)	+3,750			3,750 direct	Filing · EDGAR
Jul 30, 2008	Grant or award from the company	+5,000			5,000 direct	Filing · EDGAR
Jul 30, 2008	Grant or award from the company Stock Option (Right to Buy)	+10,000			10,000 direct	Filing · EDGAR

Tercica Director · filings 2004 to 2008

Date	Transaction	Shares	Price	Value	Held after	Source
Oct 16, 2008	Returned to the company	−10,000	$9.00	$90K	0 direct	Filing · EDGAR
Oct 16, 2008	Returned to the company	−3,333	$9.00	$30K	0 direct	Filing · EDGAR
Oct 16, 2008	Returned to the company Non-Qualified Stock Option (right to buy)	−12,500	$4.00	$50K	0 direct	Filing · EDGAR
Oct 16, 2008	Returned to the company Non-Qualified Stock Option (right to buy)	−11,250	$8.25	$93K	0 direct	Filing · EDGAR
Oct 16, 2008	Returned to the company Non-Qualified Stock Option (right to buy)	−11,250	$4.60	$52K	0 direct	Filing · EDGAR
Oct 16, 2008	Returned to the company Non-Qualified Stock Option (right to buy)	−11,250	$6.60	$74K	0 direct	Filing · EDGAR
Oct 16, 2008	Returned to the company Non-Qualified Stock Option (right to buy)	−13,334	$4.19	$56K	0 direct	Filing · EDGAR
May 20, 2008	Grant or award from the company	+3,333			13,333 direct	Filing · EDGAR
May 20, 2008	Grant or award from the company Non-Qualified stock option (right to buy)	+13,334			13,334 direct	Filing · EDGAR
May 24, 2007	Grant or award from the company Non-Qualified Stock Options (right to buy)	+11,250			11,250 direct	Filing · EDGAR
Jun 6, 2006	Grant or award from the company Non-Qualified Stock Options (right to buy)	+11,250			11,250 direct	Filing · EDGAR
Jun 1, 2005	Grant or award from the company Non-Qualified Stock Options (right to buy)	−11,250			11,250 direct	Filing · EDGAR

SGX Pharmaceuticals Director · filings 2006 to 2008

Date	Transaction	Shares	Price	Value	Held after	Source
Aug 20, 2008	Returned to the company	−12,500	$3.00	$38K	0 direct	Filing · EDGAR
Aug 20, 2008	Returned to the company Non-Qualified Stock Option (right to buy)	−10,000	$1.65	$17K	0 direct	Filing · EDGAR
Aug 20, 2008	Returned to the company Non-Qualified Stock Option (right to buy)	−20,000			0 direct	Filing · EDGAR
Jun 5, 2008	Grant or award from the company Non-Qualified Stock Option (right to buy)	+10,000			10,000 direct	Filing · EDGAR
May 17, 2007	Grant or award from the company Non-Qualified Stock Option (right to buy)	+10,000			20,000 direct	Filing · EDGAR
May 17, 2007	Grant or award from the company Non-Qualified Stock Option (right to buy)	+10,000			10,000 direct	Filing · EDGAR

Diversa Sr. VP Finance, CFO & Sec. · filings 2003 to 2004 · sold $669K

Date	Transaction	Shares	Price	Value	Held after	Source
Apr 29, 2004	Sale under a 10b5-1 plan	−9,410	$10.50	$99K	7,009 direct	Filing · EDGAR
Apr 29, 2004	Sale under a 10b5-1 plan	−590	$10.50	$6K	6,419 direct	Filing · EDGAR
Apr 26, 2004	Option or RSU exercised or converted	+11,168	$1.73	$19K	27,587 direct	Filing · EDGAR
Apr 26, 2004	Option or RSU exercised or converted	+2,800	$1.73	$5K	30,387 direct	Filing · EDGAR
Apr 26, 2004	Option or RSU exercised or converted	+5,000	$1.73	$9K	35,387 direct	Filing · EDGAR
Apr 26, 2004	Option or RSU exercised or converted	+8,836	$1.73	$15K	44,223 direct	Filing · EDGAR
Apr 26, 2004	Option or RSU exercised or converted	+600	$1.73	$1K	44,823 direct	Filing · EDGAR
Apr 26, 2004	Option or RSU exercised or converted	+1,500	$1.73	$3K	46,323 direct	Filing · EDGAR
Apr 26, 2004	Option or RSU exercised or converted	+4,796	$1.73	$8K	51,119 direct	Filing · EDGAR
Apr 26, 2004	Option or RSU exercised or converted	+300	$1.73	$519	51,419 direct	Filing · EDGAR
Apr 26, 2004	Open-market or private sale	−11,168	$10.00	$112K	40,251 direct	Filing · EDGAR
Apr 26, 2004	Open-market or private sale	−2,800	$10.01	$28K	37,451 direct	Filing · EDGAR
Apr 26, 2004	Open-market or private sale	−5,000	$10.05	$50K	32,451 direct	Filing · EDGAR
Apr 26, 2004	Open-market or private sale	−8,836	$10.10	$89K	23,615 direct	Filing · EDGAR
Apr 26, 2004	Open-market or private sale	−600	$10.20	$6K	23,015 direct	Filing · EDGAR
Apr 26, 2004	Open-market or private sale	−1,500	$10.30	$15K	21,515 direct	Filing · EDGAR
Apr 26, 2004	Open-market or private sale	−4,796	$10.33	$50K	16,719 direct	Filing · EDGAR
Apr 26, 2004	Open-market or private sale	−300	$10.34	$3K	16,419 direct	Filing · EDGAR
Apr 26, 2004	Option or RSU exercised or converted Employee Stock Option (Right to Buy)	−11,168	$10.00	$112K	74,763 direct	Filing · EDGAR
Apr 26, 2004	Option or RSU exercised or converted Employee Stock Option (Right to Buy)	−2,800	$10.01	$28K	71,963 direct	Filing · EDGAR
Apr 26, 2004	Option or RSU exercised or converted Employee Stock Option (Right to Buy)	−5,000	$10.05	$50K	66,963 direct	Filing · EDGAR
Apr 26, 2004	Option or RSU exercised or converted Employee Stock Option (Right to Buy)	−8,836	$10.10	$89K	58,127 direct	Filing · EDGAR
Apr 26, 2004	Option or RSU exercised or converted Employee Stock Option (Right to Buy)	−600	$10.20	$6K	57,527 direct	Filing · EDGAR
Apr 26, 2004	Option or RSU exercised or converted Employee Stock Option (Right to Buy)	−1,500	$10.30	$15K	56,027 direct	Filing · EDGAR
Apr 26, 2004	Option or RSU exercised or converted Employee Stock Option (Right to Buy)	−4,796	$10.33	$50K	51,231 direct	Filing · EDGAR
Apr 26, 2004	Option or RSU exercised or converted Employee Stock Option (Right to Buy)	−300	$10.34	$3K	50,931 direct	Filing · EDGAR
Feb 12, 2004	Grant or award from the company Employee Stock Option (Right to Buy)	+15,473			15,473 direct	Filing · EDGAR
Feb 12, 2004	Grant or award from the company Non-Qualified Stock Option (Right to Buy)	+84,527			84,527 direct	Filing · EDGAR
Feb 12, 2004	Grant or award from the company Non-Qualified Stock Option (Right to Buy)	+15,282			99,809 direct	Filing · EDGAR
Jan 15, 2004	Sale under a 10b5-1 plan	−1,112	$10.50	$12K	16,419 direct	Filing · EDGAR
Jan 14, 2004	Sale under a 10b5-1 plan	−1,100	$10.50	$12K	22,531 direct	Filing · EDGAR
Jan 14, 2004	Sale under a 10b5-1 plan	−200	$10.55	$2K	22,331 direct	Filing · EDGAR
Jan 14, 2004	Sale under a 10b5-1 plan	−300	$10.60	$3K	22,031 direct	Filing · EDGAR
Jan 14, 2004	Sale under a 10b5-1 plan	−300	$10.61	$3K	21,731 direct	Filing · EDGAR
Jan 14, 2004	Sale under a 10b5-1 plan	−100	$10.65	$1K	21,631 direct	Filing · EDGAR
Jan 14, 2004	Sale under a 10b5-1 plan	−200	$10.66	$2K	21,431 direct	Filing · EDGAR
Jan 14, 2004	Sale under a 10b5-1 plan	−300	$10.67	$3K	21,131 direct	Filing · EDGAR
Jan 14, 2004	Sale under a 10b5-1 plan	−1,600	$10.70	$17K	19,531 direct	Filing · EDGAR
Jan 14, 2004	Sale under a 10b5-1 plan	−400	$10.71	$4K	19,131 direct	Filing · EDGAR
Jan 14, 2004	Sale under a 10b5-1 plan	−500	$10.73	$5K	18,631 direct	Filing · EDGAR
Jan 14, 2004	Sale under a 10b5-1 plan	−500	$10.74	$5K	18,131 direct	Filing · EDGAR
Jan 14, 2004	Sale under a 10b5-1 plan	−500	$10.76	$5K	17,631 direct	Filing · EDGAR
Jan 14, 2004	Sale under a 10b5-1 plan	−100	$10.82	$1K	17,531 direct	Filing · EDGAR
Jan 13, 2004	Sale under a 10b5-1 plan	−388	$10.61	$4K	25,031 direct	Filing · EDGAR
Jan 13, 2004	Sale under a 10b5-1 plan	−100	$10.56	$1K	24,931 direct	Filing · EDGAR
Jan 13, 2004	Sale under a 10b5-1 plan	−1,000	$10.50	$11K	23,931 direct	Filing · EDGAR
Jan 13, 2004	Sale under a 10b5-1 plan	−300	$10.51	$3K	23,631 direct	Filing · EDGAR
Jan 12, 2004	Sale under a 10b5-1 plan	−1,000	$10.52	$11K	35,419 direct	Filing · EDGAR
Jan 12, 2004	Sale under a 10b5-1 plan	−10,000	$10.50	$105K	25,419 direct	Filing · EDGAR

All 192 Forms 3, 4, 5 and 144

Filed	Form	Company	Links
Oct 28, 2026	Form 4	Veracyte VCYT	Filing · EDGAR
Oct 27, 2026	Form 144	Veracyte VCYT	Filing · EDGAR
Jun 22, 2026	Form 4	Veracyte VCYT	Filing · EDGAR
Jun 18, 2026	Form 144	Veracyte VCYT	Filing · EDGAR
Jun 15, 2026	Form 4	Veracyte VCYT	Filing · EDGAR
Jun 11, 2026	Form 4/A	Personalis PSNL	Filing · EDGAR
May 14, 2026	Form 4	Personalis PSNL	Filing · EDGAR
Dec 8, 2025	Form 4	Veracyte VCYT	Filing · EDGAR
Dec 5, 2025	Form 144	Veracyte VCYT	Filing · EDGAR
Nov 7, 2025	Form 4	Veracyte VCYT	Filing · EDGAR
Nov 5, 2025	Form 144	Veracyte VCYT	Filing · EDGAR
Jun 23, 2025	Form 4	Veracyte VCYT	Filing · EDGAR
Jun 17, 2025	Form 4	Veracyte VCYT	Filing · EDGAR
Jun 13, 2025	Form 144	Veracyte VCYT	Filing · EDGAR
May 20, 2025	Form 4	Personalis PSNL	Filing · EDGAR
Jan 6, 2025	Form 4	Veracyte VCYT	Filing · EDGAR
Jan 2, 2025	Form 144	Veracyte VCYT	Filing · EDGAR
Nov 21, 2024	Form 4	Veracyte VCYT	Filing · EDGAR
Nov 19, 2024	Form 144	Veracyte VCYT	Filing · EDGAR
Jul 18, 2024	Form 4	Veracyte VCYT	Filing · EDGAR
Jul 16, 2024	Form 144	Veracyte VCYT	Filing · EDGAR
Jun 17, 2024	Form 4	Veracyte VCYT	Filing · EDGAR
Jun 13, 2024	Form 4	Veracyte VCYT	Filing · EDGAR
Jun 11, 2024	Form 144	Veracyte VCYT	Filing · EDGAR
Jun 11, 2024	Form 4	Veracyte VCYT	Filing · EDGAR
Jun 7, 2024	Form 144	Veracyte VCYT	Filing · EDGAR
May 21, 2024	Form 4	Personalis PSNL	Filing · EDGAR
Apr 2, 2024	Form 4	Veracyte VCYT	Filing · EDGAR
Apr 1, 2024	Form 144	Veracyte VCYT	Filing · EDGAR
Jun 13, 2023	Form 4	Veracyte VCYT	Filing · EDGAR
May 19, 2023	Form 4	Personalis PSNL	Filing · EDGAR
Mar 17, 2023	Form 4	Veracyte VCYT	Filing · EDGAR
Mar 2, 2023	Form 4	Veracyte VCYT	Filing · EDGAR
Jan 17, 2023	Form 4	Geron	Filing · EDGAR
Sep 20, 2022	Form 4	Nektar Therapeutics	Filing · EDGAR
Sep 14, 2022	Form 4	Nektar Therapeutics	Filing · EDGAR
Jun 16, 2022	Form 4	Veracyte VCYT	Filing · EDGAR
May 19, 2022	Form 4	Personalis PSNL	Filing · EDGAR
May 11, 2022	Form 4	Geron	Filing · EDGAR
Apr 21, 2022	Form 4	Geron	Filing · EDGAR
Dec 20, 2021	Form 4	Veracyte VCYT	Filing · EDGAR
Nov 3, 2021	Form 4	Veracyte VCYT	Filing · EDGAR
Sep 24, 2021	Form 4	Nektar Therapeutics	Filing · EDGAR
Aug 4, 2021	Form 4	Veracyte VCYT	Filing · EDGAR
Jun 10, 2021	Form 4	Veracyte VCYT	Filing · EDGAR
May 18, 2021	Form 4	Personalis PSNL	Filing · EDGAR
May 13, 2021	Form 4	Geron	Filing · EDGAR
May 5, 2021	Form 4	Veracyte VCYT	Filing · EDGAR
May 5, 2021	Form 4/A	Veracyte VCYT	Filing · EDGAR
Feb 26, 2021	Form 4	Veracyte VCYT	Filing · EDGAR
Sep 25, 2020	Form 4/A	Nektar Therapeutics	Filing · EDGAR
Sep 24, 2020	Form 4	Nektar Therapeutics	Filing · EDGAR
Jun 9, 2020	Form 4	Veracyte VCYT	Filing · EDGAR
Jun 9, 2020	Form 4	Geron	Filing · EDGAR
May 19, 2020	Form 4	Personalis PSNL	Filing · EDGAR
Sep 27, 2019	Form 4	Nektar Therapeutics	Filing · EDGAR
Sep 16, 2019	Form 4	Personalis PSNL	Filing · EDGAR
Sep 16, 2019	Form 3	Personalis PSNL	Filing · EDGAR
Jun 13, 2019	Form 4	Veracyte VCYT	Filing · EDGAR
Jun 7, 2019	Form 4	Geron	Filing · EDGAR
May 28, 2019	Form 4	Illumina	Filing · EDGAR
Jan 4, 2019	Form 4	Illumina	Filing · EDGAR
Oct 1, 2018	Form 4	Nektar Therapeutics	Filing · EDGAR
Oct 1, 2018	Form 3	Nektar Therapeutics	Filing · EDGAR
Jun 7, 2018	Form 4	Veracyte VCYT	Filing · EDGAR
May 24, 2018	Form 4	Illumina	Filing · EDGAR
May 22, 2018	Form 4	Illumina	Filing · EDGAR
May 17, 2018	Form 4	Geron	Filing · EDGAR
Mar 6, 2018	Form 4	Illumina	Filing · EDGAR
Aug 4, 2017	Form 4	Illumina	Filing · EDGAR
Jun 7, 2017	Form 4	Veracyte VCYT	Filing · EDGAR
Jun 1, 2017	Form 4	Illumina	Filing · EDGAR
May 22, 2017	Form 4	Illumina	Filing · EDGAR
May 10, 2017	Form 4	Geron	Filing · EDGAR
Jun 20, 2016	Form 4	Veracyte VCYT	Filing · EDGAR
Jun 3, 2016	Form 4	Illumina	Filing · EDGAR
May 19, 2016	Form 4	Illumina	Filing · EDGAR
May 19, 2016	Form 4	Geron	Filing · EDGAR
Feb 16, 2016	Form 5	Illumina	Filing · EDGAR
Sep 8, 2015	Form 4	Illumina	Filing · EDGAR
Jun 3, 2015	Form 4	Illumina	Filing · EDGAR
May 28, 2015	Form 4	Illumina	Filing · EDGAR
May 21, 2015	Form 4	Veracyte VCYT	Filing · EDGAR
May 19, 2015	Form 4	Geron	Filing · EDGAR
Feb 3, 2015	Form 4	Illumina	Filing · EDGAR
Jan 5, 2015	Form 4	Illumina	Filing · EDGAR
Jan 2, 2015	Form 4	Geron	Filing · EDGAR
Dec 5, 2014	Form 4	Illumina	Filing · EDGAR
Jul 29, 2014	Form 4	Illumina	Filing · EDGAR
Jul 2, 2014	Form 4	Geron	Filing · EDGAR
Jun 3, 2014	Form 4	Illumina	Filing · EDGAR
May 29, 2014	Form 4	Illumina	Filing · EDGAR
May 21, 2014	Form 4	Veracyte VCYT	Filing · EDGAR
May 21, 2014	Form 4	Geron	Filing · EDGAR
Jan 6, 2014	Form 4	Illumina	Filing · EDGAR
Jan 3, 2014	Form 4	Geron	Filing · EDGAR
Nov 5, 2013	Form 4	Illumina	Filing · EDGAR
Nov 4, 2013	Form 4	Veracyte VCYT	Filing · EDGAR
Oct 29, 2013	Form 3	Veracyte VCYT	Filing · EDGAR
Sep 13, 2013	Form 4	Trius Therapeutics	Filing · EDGAR
Jul 10, 2013	Form 4	Geron	Filing · EDGAR
Jun 5, 2013	Form 4	Illumina	Filing · EDGAR
May 31, 2013	Form 4	Illumina	Filing · EDGAR
May 24, 2013	Form 4	Geron	Filing · EDGAR
May 23, 2013	Form 4	Trius Therapeutics	Filing · EDGAR
Apr 22, 2013	Form 4	Illumina	Filing · EDGAR
Jan 3, 2013	Form 4	Geron	Filing · EDGAR
Aug 10, 2012	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Jun 5, 2012	Form 4	Illumina	Filing · EDGAR
May 24, 2012	Form 4	Trius Therapeutics	Filing · EDGAR
May 18, 2012	Form 4	Geron	Filing · EDGAR
May 17, 2012	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Apr 20, 2012	Form 4	Illumina	Filing · EDGAR
Mar 29, 2012	Form 4	Trius Therapeutics	Filing · EDGAR
Jun 6, 2011	Form 4	Trius Therapeutics	Filing · EDGAR
Jun 3, 2011	Form 4	Illumina	Filing · EDGAR
May 25, 2011	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
May 24, 2011	Form 4	Geron	Filing · EDGAR
May 13, 2011	Form 4	Geron	Filing · EDGAR
May 11, 2011	Form 4	Illumina	Filing · EDGAR
Mar 21, 2011	Form 4	Illumina	Filing · EDGAR
Mar 7, 2011	Form 4	Genoptix	Filing · EDGAR
Mar 1, 2011	Form 4	Genoptix	Filing · EDGAR
Dec 3, 2010	Form 4	Genoptix	Filing · EDGAR
Nov 5, 2010	Form 4	Trius Therapeutics	Filing · EDGAR
Sep 3, 2010	Form 4	Genoptix	Filing · EDGAR
Aug 10, 2010	Form 4	Trius Therapeutics	Filing · EDGAR
Aug 2, 2010	Form 3	Trius Therapeutics	Filing · EDGAR
Jul 13, 2010	Form 4	Geron	Filing · EDGAR
Jun 3, 2010	Form 4	Genoptix	Filing · EDGAR
Jun 3, 2010	Form 4	Illumina	Filing · EDGAR
May 21, 2010	Form 4	Geron	Filing · EDGAR
May 12, 2010	Form 4	Illumina	Filing · EDGAR
Apr 30, 2010	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Mar 4, 2010	Form 4	Genoptix	Filing · EDGAR
Dec 4, 2009	Form 4	Genoptix	Filing · EDGAR
Oct 6, 2009	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Sep 4, 2009	Form 4	Genoptix	Filing · EDGAR
Jul 9, 2009	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Jun 10, 2009	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Jun 4, 2009	Form 4	Genoptix	Filing · EDGAR
Jun 3, 2009	Form 4	Illumina	Filing · EDGAR
Jun 1, 2009	Form 4	Geron	Filing · EDGAR
May 11, 2009	Form 4	Illumina	Filing · EDGAR
Apr 7, 2009	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Apr 2, 2009	Form 3	Geron	Filing · EDGAR
Jan 15, 2009	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Oct 20, 2008	Form 4	Tercica	Filing · EDGAR
Oct 6, 2008	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Aug 21, 2008	Form 4	SGX Pharmaceuticals	Filing · EDGAR
Aug 1, 2008	Form 4	Genoptix	Filing · EDGAR
Aug 1, 2008	Form 3	Genoptix	Filing · EDGAR
Jul 7, 2008	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Jun 11, 2008	Form 4	SGX Pharmaceuticals	Filing · EDGAR
Jun 4, 2008	Form 4	Illumina	Filing · EDGAR
May 30, 2008	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
May 21, 2008	Form 4	Tercica	Filing · EDGAR
May 20, 2008	Form 4	Illumina	Filing · EDGAR
Apr 4, 2008	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Jan 14, 2008	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Oct 9, 2007	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Jul 25, 2007	Form 4	Illumina	Filing · EDGAR
Jul 10, 2007	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
May 24, 2007	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
May 24, 2007	Form 4	Tercica	Filing · EDGAR
May 18, 2007	Form 4	SGX Pharmaceuticals	Filing · EDGAR
May 17, 2007	Form 4	SGX Pharmaceuticals	Filing · EDGAR
Apr 5, 2007	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Mar 2, 2007	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Jan 17, 2007	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Oct 11, 2006	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Jul 26, 2006	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Jun 16, 2006	Form 4/A	Tercica	Filing · EDGAR
Jun 16, 2006	Form 4	Tercica	Filing · EDGAR
Jun 9, 2006	Form 4	Illumina	Filing · EDGAR
May 19, 2006	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
May 8, 2006	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Mar 7, 2006	Form 4	Amylin Pharmaceuticals	Filing · EDGAR
Feb 14, 2006	Form 5	Amylin Pharmaceuticals	Filing · EDGAR
Jan 31, 2006	Form 3	SGX Pharmaceuticals	Filing · EDGAR
Sep 30, 2005	Form 3	Amylin Pharmaceuticals	Filing · EDGAR
Jun 30, 2005	Form 4	Illumina	Filing · EDGAR
Jun 3, 2005	Form 4	Tercica	Filing · EDGAR
Aug 3, 2004	Form 4	Illumina	Filing · EDGAR
Aug 3, 2004	Form 3	Illumina	Filing · EDGAR
May 3, 2004	Form 4	Diversa	Filing · EDGAR
Apr 28, 2004	Form 4	Diversa	Filing · EDGAR
Mar 16, 2004	Form 3	Tercica	Filing · EDGAR
Feb 17, 2004	Form 4	Diversa	Filing · EDGAR
Jan 15, 2004	Form 4	Diversa	Filing · EDGAR
Jan 13, 2004	Form 4	Diversa	Filing · EDGAR
Jul 14, 2003	Form 4	Diversa	Filing · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched Nov 8, 2026, 6:44 AM ET. The filing on SEC.gov is the record.